Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Overcoming Challenges in Fluorine-Based Chemistry

Fluorinated molecules are important as pharmaceutical compounds. Recent advances involve selective and late-stage insertion of fluorine into small molecules.
Oct 2, 2013

Fluorinated molecules play an important role as pharmaceutical compounds. Recent advances seek to overcome the challenges of selective and late-stage insertion of fluorine into small molecules.

AstraZeneca, Bristol-Myers Squibb Recall Certain Lots of Bydureon

Sep 24, 2013

AstraZeneca, Bristol-Myers Squibb recall certain lots of of their antidiabetes drug Bydureon (eventide) due to manufacturing records that batches may contain underfilled vials.

Amgen’s Acqusition of Onyx Leads Biopharmaceutical Dealmaking in 2013

Mergers and acquisition activity on both a volume and value basis is up thus far in 2013 comparative to 2012.
Sep 4, 2013

Mergers and acquisition activity on both a volume and value basis is up thus far in 2013 comparative to 2012.

CROs Face Issues with Talent Retention

A recent survey shows that talent retention is an issue on industry level for contract research organizations (CROs), particularly for CROs located outside the United States.
Sep 4, 2013

A recent survey shows that talent retention is an issue on industry level for contract research organizations (CROs), particularly for CROs located outside the United States.

Advancing Chiral Chemistry in Pharmaceutical Synthesis

Sep 2, 2013

Developments involve stereoretentive cross-coupling, enantioselective alcohol silylation, strategies for amplifying signals in circular dichroism spectroscopy, and a synthetic route for the natural product ingenol.

Quality by Design in APIs

The adoption of quality by design in small-molecule drug development and manufacturing continues to evolve as the industry seeks ways to augment process understanding for APIs
Sep 2, 2013

The adoption of quality by design in small-molecule drug development and manufacturing continues to evolve as the industry seeks ways to augment process understanding for APIs

Risk Assessment of Excipients

Sep 1, 2013

Industry experts share perspectives on risk assessment and mitigation in excipient manufacture and the excipient supply chain.

Gaining Insights on Contract Chemical API Manufacturing

Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.
Sep 1, 2013

Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.

Siegfried Proceeds with Expansion in China and Switzerland

Aug 27, 2013

Siegfried is proceeding with its expansion in China and Switzerland.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here